Correlation Between Dianthus Therapeutics and Exicure
Can any of the company-specific risk be diversified away by investing in both Dianthus Therapeutics and Exicure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dianthus Therapeutics and Exicure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dianthus Therapeutics and Exicure, you can compare the effects of market volatilities on Dianthus Therapeutics and Exicure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dianthus Therapeutics with a short position of Exicure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dianthus Therapeutics and Exicure.
Diversification Opportunities for Dianthus Therapeutics and Exicure
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Dianthus and Exicure is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Dianthus Therapeutics and Exicure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exicure and Dianthus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dianthus Therapeutics are associated (or correlated) with Exicure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exicure has no effect on the direction of Dianthus Therapeutics i.e., Dianthus Therapeutics and Exicure go up and down completely randomly.
Pair Corralation between Dianthus Therapeutics and Exicure
Given the investment horizon of 90 days Dianthus Therapeutics is expected to under-perform the Exicure. But the stock apears to be less risky and, when comparing its historical volatility, Dianthus Therapeutics is 5.72 times less risky than Exicure. The stock trades about -0.01 of its potential returns per unit of risk. The Exicure is currently generating about 0.27 of returns per unit of risk over similar time horizon. If you would invest 174.00 in Exicure on September 6, 2024 and sell it today you would earn a total of 1,978 from holding Exicure or generate 1136.78% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Dianthus Therapeutics vs. Exicure
Performance |
Timeline |
Dianthus Therapeutics |
Exicure |
Dianthus Therapeutics and Exicure Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Dianthus Therapeutics and Exicure
The main advantage of trading using opposite Dianthus Therapeutics and Exicure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dianthus Therapeutics position performs unexpectedly, Exicure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exicure will offset losses from the drop in Exicure's long position.Dianthus Therapeutics vs. Candel Therapeutics | Dianthus Therapeutics vs. Cingulate Warrants | Dianthus Therapeutics vs. Unicycive Therapeutics | Dianthus Therapeutics vs. Cardio Diagnostics Holdings |
Exicure vs. Ikena Oncology | Exicure vs. Eliem Therapeutics | Exicure vs. HCW Biologics | Exicure vs. RenovoRx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |